|
|
PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers
V. Vendrely
,
C. Lemanski
,
E. Le Prise
,
E. Maillard
,
X. Mirabel
et al.
ESTRO 36, May 2017, Vienne, Austria. , Radiotherapy and Oncology, 123 (Supplement 1), pp.S367 - S368, 2017, ESTRO 36, May 5-9, 2017, Vienna, Austria. ⟨10.1016/S0167-8140(17)31139-8⟩
Poster de conférence
hal-01685153v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics
C. Lepage
,
M. Phelip
,
L. Cany
,
E. Maillard
,
A. Lievre
et al.
41st Congress of the European-Society-for-Medical-Oncology (ESMO), Oct 2016, Copenhague, Denmark. pp.483P, ⟨10.1093/annonc/mdw370.31⟩
Communication dans un congrès
hal-01507441v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20
T. Aparicio
,
O. Bouché
,
E. Francois
,
E. Maillard
,
S. Kirscher
et al.
Communication dans un congrès
hal-01524852v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial
J-B. Bachet
,
O. Lucidarme
,
C.B. Levache
,
E. Maillard
,
J.L. Raoul
et al.
Communication dans un congrès
hal-01632415v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation
P. Michel
,
T. André
,
V. Boige
,
T. Aparicio
,
E. Maillard
et al.
Communication dans un congrès
hal-01632463v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results
T. Aparicio
,
O. Bouché
,
J. Taieb
,
E. Maillard
,
S. Kirscher
et al.
Article dans une revue
hal-01699429v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD
T. Aparicio
,
A. Darut-Jouve
,
F. Khemissa Akouz
,
C. Montérymard
,
P. Artru
et al.
Article dans une revue
hal-02901884v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22)
M. Karoui
,
A. Rullier
,
C. Mariette
,
E. Maillard
,
A. Bardier
et al.
Communication dans un congrès
hal-01632311v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|